Miiru Izumi

901 total citations
31 papers, 660 citations indexed

About

Miiru Izumi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Miiru Izumi has authored 31 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Surgery. Recurrent topics in Miiru Izumi's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Miiru Izumi is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Miiru Izumi collaborates with scholars based in Japan, United States and Australia. Miiru Izumi's co-authors include Yoichi Nakanishi, Koichi Takayama, Taishi Harada, Nobuyuki Hara, Kazuto Furuyama, Kyoko Okamura, Takahiro Minami, Ichiro Yoshino, Naoko Inoshima and Koji Inoue and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Medicine.

In The Last Decade

Miiru Izumi

28 papers receiving 650 citations

Peers

Countries citing papers authored by Miiru Izumi

Since Specialization

Citations

This map shows the geographic impact of Miiru Izumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miiru Izumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miiru Izumi more than expected).

Fields of papers citing papers by Miiru Izumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miiru Izumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miiru Izumi. The network helps show where Miiru Izumi may publish in the future.

Co-authorship network of co-authors of Miiru Izumi

This figure shows the co-authorship network connecting the top 25 collaborators of Miiru Izumi. A scholar is included among the top collaborators of Miiru Izumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miiru Izumi. Miiru Izumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study 2024 ·BMC Pulmonary Medicine ·(unknown), Nobuhiko Nagata, Hiroyuki Kumazoe, Makiko Hara, Satomi Asai, Naotaka Noda, (unknown), (unknown), (unknown), (unknown), Takashi Akasaki, Sanae Maki, (unknown), (unknown), Miiru Izumi, Masayuki Kawasaki, Hozumi Yamada	0
2	Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial 2023 ·Cancer Medicine ·Masahiro Iwasaku, Junji Uchino, (unknown), (unknown), Takahiro Yamada, Kazunori Tobino, (unknown), Takashi Kijima, Katsumi Nakatomi, Miiru Izumi, Nobuyo Tamiya, Hideharu Kimura, Masaki Fujita, Ryoichi Honda, (unknown), Tadaaki Yamada, Yoshiko Kaneko, Fumiaki Kiyomi, Koichi Takayama	3
3	A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L) 2023 ·JTO Clinical and Research Reports ·Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, Minoru Fukuda, Kentaro Ito, (unknown), Kentaro Tanaka, Taishi Harada, Yuki Nakatani, Satoru Miura, Toshihide Yokoyama, Tomomi Nakamura, Miiru Izumi, Atsushi Nakamura, Satoshi Ikeda, Koichi Takayama, Kenichi Yoshimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kenji Sugio	0
4	Efficacy of steroid pulse therapy for miliary tuberculosis complicated by acute respiratory distress syndrome 2022 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, Satoshi Honjo, (unknown), (unknown), Makiko Hara, (unknown), Naotaka Noda, (unknown), (unknown), (unknown), (unknown), Takashi Akasaki, Sanae Maki, Miiru Izumi, Masayuki Kawasaki, (unknown)	1
5	Combination immunotherapy of nivolumab plus ipilimumab in a lung cancer patient with Werner syndrome; a case report 2022 ·Respiratory Medicine Case Reports ·(unknown), Miiru Izumi, (unknown), Tsuyoshi Ueno, (unknown), (unknown), Naotaka Noda, Makiko Hara, Junji Otsuka, Kentaro Wakamatsu, Masayuki Kawasaki	0
6	Comfort and safety of bronchoscopy performed under sedation and local anesthesia in elderly patients 2020 ·Medicine ·Naotaka Noda, Makiko Hara, (unknown), (unknown), (unknown), (unknown), Miiru Izumi, Kentaro Wakamatsu, Masayuki Kawasaki	8
7	Prognostic factors in patients with miliary tuberculosis 2018 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, (unknown), Makiko Hara, (unknown), Naotaka Noda, (unknown), (unknown), (unknown), Erika Yamada, Takashi Akasaki, Sanae Maki, (unknown), Miiru Izumi, Masayuki Kawasaki	12
8	Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis 2016 ·Respiratory Investigation ·Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, Keishi Oda, Hiroshi Ishimoto, Michihiro Yoshimi, Shohei Takata, (unknown), (unknown), (unknown), (unknown), Makiko Hara, (unknown), Miiru Izumi, Takashi Akasaki, Sanae Maki, Masaharu Kawabata, Hiroshi Mukae, Masayuki Kawasaki	92
9	A Case of Multiple Squamous Cell Papillomas of the Trachea 2011 ·Annals of Thoracic and Cardiovascular Surgery ·(unknown), Miiru Izumi, Koichi Takayama, Torahiko Nakashima, Hiromasa Inoue, Yoichi Nakanishi	3
10	Phase II study of uracil‐tegafur plus cisplatin in patients with previously untreated advanced non‐small cell lung cancer 2008 ·Respirology ·Koichi Takayama, Masayuki Kawasaki, Kiyoshi Ninomiya, Akira Motohiro, Masaki Fujita, Kentaro Watanabe, Akira Kajiki, (unknown), Naoki Miyazaki, Miiru Izumi, Nobuyuki Hara, Yoichi Nakanishi, (unknown)	3
11	Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer. 2008 ·PubMed ·(unknown), Koichi Takayama, Miiru Izumi, Taishi Harada, Yasuhiro Horiuchi, Junji Uchino, Nobuyuki Hara, Yoichi Nakanishi	24
12	A Case of Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Lung and Bronchus 2007 ·Haigan ·Makoto Nakagawa, Toshihiro Osaki, Miiru Izumi, Takahiro Minami, (unknown)	1
13	Targeting lung cancer using an infectivity enhanced CXCR4-CRAd 2006 ·Lung Cancer ·Zeng B. Zhu, Ángel A. Rivera, Sharmila Makhija, Baogen Lu, Minghui Wang, Miiru Izumi, Robert J. Cerfolio, Mariam A. Stoff‐Khalili, Fen Zhou, Koichi Takayama, Gene P. Siegal, David T. Curiel	10
14	Intralobar sequestration with tuberculous infection confined to the sequestrated lung 2005 ·Respirology ·Kazuhiro Yatera, Miiru Izumi, Makoto Imai, (unknown), Naoki Miyazaki, Masamitsu Kido	11
15	In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model 2005 ·The Journal of Gene Medicine ·Miiru Izumi, Yosuke Kawakami, Joel N. Glasgow, Н. В. Белоусова, Maaike Everts, (unknown), Seiji Yamamoto, Minghui Wang, Long P. Le, Paul N. Reynolds, David T. Curiel	16
16	Codon 64 of K-ras gene mutation pattern in hepatocellular carcinomas induced by bleomycin and 1-nitropyrene in A/J mice 2003 ·Teratogenesis Carcinogenesis and Mutagenesis ·Feng Bai, Yoichi Nakanishi, Koichi Takayama, Xin‐Hai Pei, Koji Inoue, Taishi Harada, Miiru Izumi, Nobuyuki Hara	16
17	Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors 2002 ·Chemotherapy ·Yoichi Nakanishi, Koichi Takayama, Hiroshi Wataya, Miiru Izumi, Takahiro Minami, Koichi Takano, Koji Inoue, (unknown), (unknown), Taishi Harada, Nobuyuki Hara	5
18	Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma 2001 ·Cancer ·Miiru Izumi, Yoichi Nakanishi, (unknown), Manabu Nakashima, Takeshi Watanabe, (unknown)	56
19	Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma 2001 ·Cancer ·Miiru Izumi, Yoichi Nakanishi, Koichi Takayama, (unknown), Koji Inoue, Hiroshi Wataya, Takahiro Minami, Nobuyuki Hara	36
20	Polycyclic Aromatic Hydrocarbon Carcinogens Increase Ubiquitination of p21 Protein after the Stabilization of p53 and the Expression of p21 2000 ·American Journal of Respiratory Cell and Molecular Biology ·Yoichi Nakanishi, Xin‐Hai Pei, Koichi Takayama, Feng Bai, Miiru Izumi, (unknown), Koji Inoue, Takahiro Minami, Hiroshi Wataya, Nobuyuki Hara	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact